Evidence map›Paper›PMID 38808245›Full record

ReviewRSC advances2024

Advances in chromone-based copper(ii) Schiff base complexes: synthesis, characterization, and versatile applications in pharmacology and biomimetic catalysis.

Sumit Kumar, Aditi Arora, Vipin K Maikhuri, Ankita Chaudhary, Rajesh Kumar, Virinder S Parmar, Brajendra K Singh, Divya Mathur

Abstract readReview
In one paragraph

Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Reusable Pd/TiOMolecular diversity · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Square planarRSC advances · 2025
    Article
  12. Novel insights into cuproptosis inducers and inhibitors.Frontiers in molecular biosciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sumit KumarDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.
Aditi AroraDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.
Vipin K MaikhuriDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.ORCID https://orcid.org/0000-0002-4294-833X
Ankita ChaudharyDepartment of Chemistry, Maitreyi College, University of Delhi Delhi India.
Rajesh KumarDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.
Virinder S ParmarDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.
Brajendra K SinghDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.ORCID https://orcid.org/0000-0002-6324-3996
Divya MathurDepartment of Chemistry, Bioorganic Research Laboratory, University of Delhi Delhi India singhbk@chemistry.du.ac.in.ORCID https://orcid.org/0000-0002-0277-1509

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromones are well known as fundamental structural elements found in numerous natural compounds and medicinal substances. The Schiff bases of chromones have a much wider range of pharmacological applications such as antitumor, antioxidant, anti-HIV, antifungal, anti-inflammatory, and antimicrobial properties. A lot of research has been carried out on chromone-based copper(ii) Schiff-base complexes owing to their role in the organometallic domain and promise as potential bioactive cores. This review article is centered on copper(ii) Schiff-base complexes derived from chromones, highlighting their diverse range of pharmacological applications documented in the past decade, as well as the future research opportunities they offer.

Identifiers

PMID38808245
PMCPMC11130647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.